Corpus 1,272 assessed · 1,173 scored · 643 reproduced ≥75 · 168 flagged ·∅ 74.1/100

Publications 3 Datasets 392.5k Experiments 4.7k

Explore

Filters: Front Pharmacol ✕ clear all

3 matching publication(s)

Publication	Journal	Year	Score	Verdict
Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma. PMID 37614318	Front Pharmacol	2023	87	L1 87/100
Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage. PMID 36438795	Front Pharmacol	2022	80	L1 80/100
NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer. ⚑ PMID 35431924	Front Pharmacol	2022	45	L1 45/100 ⚑

Identification of a novel lncRNA prognostic signature and analysis of functional lncRNA AC115619.1 in hepatocellular carcinoma.

PMID 37614318 · Front Pharmacol · 2023

L1 87/100

Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage.

PMID 36438795 · Front Pharmacol · 2022

L1 80/100

NUSAP1 Could be a Potential Target for Preventing NAFLD Progression to Liver Cancer.⚑

PMID 35431924 · Front Pharmacol · 2022

L1 45/100 ⚑